| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.22 | 0.003 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.24 | 0.02 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.12 | 0.03 |